News
Partner Therapeutics Announces Partnership with SIRS Therapeutics and F4 Pharma to Explore Potential Uses for FX06 in Biodefense Applications
- Details

eGenesis Announces $125 Million Series C Financing
- Details

Creative Balloons closes €15 million growth financing and appoints Frank Gehres as CEO
- Details
